Introduction
Although the death rate for coronary heart disease has declined over the last several decades, it is still a leading cause of death in the United States. According to AHA the estimated prevalence of coronary heart disease in USA among adults (age 20 and older), in 2005 was 16,000,000. About every 26 seconds, an american will suffer a coronary event, and about every minute someone will die from one.
More than 500,000 coronary artery bypass graft (CABG) revascularization procedures are performed annually.
Early unsuccessful attempts at myocardial revascularization by inducing pericardial adhesions took place before the 1950s. In 1951, Vineburg implanted the internal mammary artery (IMA) directly into the myocardium. Subsequent research showed that although myocardial blood flow was improved by this procedure, the additional blood flow was not enough to lead to symptomatic improvement of angina pectoris. In 1967, Favalaro and Effler at the Cleveland Clinic began performing reversed saphenous vein bypass grafting procedures, as we know them today. In 1968, Green performed an anastomosis of the IMA directly to a coronary artery. There was a resurgence of interest in the IMA grafting procedure in the late 1970s and early 1980s after a number of studies showed far greater graft patency rates for IMA grafts compared with saphenous vein grafts. In addition, better long-term survival was evident in patients receiving IMA grafts, regardless of ventricular function.
Evaluating risk of morbidity and mortality for CABG surgery
Although risk stratification tools may differ in the specific weights assigned to certain risk factors, there is agreement that certain factors are associated with increased risk of morbidity and mortality. These factors include poor left ventricular (LV) function (history of congestive heart failure or LV ejection fraction less than 30%), advanced age, obesity, emergency surgery, concomitant valve surgery, prior cardiac surgery, history of diabetes, and history of renal failure .
Myocardial oxygen supply
The viability and function of the heart are predicated upon a relatively delicate balance of oxygen supply and demand. It is of paramount importance for the cardiac anesthesiologist to understand the intricacies of this relationship. The myocardium maximally extracts O 2 from arterial blood at rest. With exertion or hemodynamic stress, the only way the O 2 supply can increase acutely to meet the myocardial energy demand is by increasing coronary blood flow (CBF). Ischemia occurs when CBF does not increase to a level sufficient to meet myocardial demand, and aerobic metabolism is impaired.
The following approach achieves the clinical goal of ensuring that O 2 supply at least matches demand:
-Optimize the determinants of myocardial O 2 supply and demand.
-Select anesthetics and adjuvant agents and techniques according to their effects on O 2 supply and demand.
-Monitor for ischemia to detect its occurrence early and intervene rapidly.
Coronary anatomy
The blood supply to the myocardium derives from the aorta through two main coronary arteries (Fig. 1) , the left and right coronary arteries. The left main coronary artery extends for a short distance (0 to 40 mm) before dividing into the left anterior descending artery and the circumflex coronary artery. Left anterior descending coronary artery. It begins as a continuation of the left main coronary artery and courses down the interventricular groove, giving rise to the diagonal and septal branches. The septal branches vary in number and size, arise in an almost perpendicular fashion from the left anterior descending artery, and provide the predominant blood supply to the interventricular septum. The septal branches also supply the bundle branches and the Purkinje system. One to three diagonal branches of variable size exist, and these branches distribute blood to the anterolateral aspect of the heart. The left anterior descending artery continues down the interventricular groove and usually passes all the way around to the apex of the LV.
Circumflex coronary artery. It arises from the left main coronary artery at almost a 90-degree angle and passes down the left atrioventricular groove. Its main vessels are the obtuse marginal branches, which range from one to three in number. They supply the lateral free wall of the LV. In 15% of patients, the circumflex artery gives rise to the posterior descending coronary artery. In 45% of patients, the sinus node artery arises from the circumflex distribution.
Right coronary artery. It passes down the right atrioventricular groove. It gives rise to acute marginal branches that supply the right anterior wall of the right ventricle. In approximately 85% of individuals, the right coronary artery gives rise to the posterior descending artery to supply the posterior inferior aspect of the LV. This blood supply pattern is classified as a right dominant system. In the majority of the population, the right coronary artery supplies a significant portion of blood flow to the LV. In the other 15% of the population, the posteriorinferior aspect of the LV is supplied by the circumflex coronary artery (left dominant system) or both right coronary and circumflex arteries (codominant system). The sinus node artery arises from the right coronary artery in 55% of patients. The atrioventricular node artery derives from the dominant coronary artery and is responsible for blood supply to the node, the bundle of His, and the proximal part of the bundle branches.
Determinants of myocardial oxygen supply.
In broad terms, the supply of oxygen to the myocardium is determined by the arterial oxygen content of the blood and the blood flow in the coronary arteries.
 Determinants of arterial oxygen content
O 2 content = (hemoglobin) (1.34) (% saturation) + (0.003) (PO 2 ) Ensuring maximal O 2 content therefore involves having a high hemoglobin level, highly saturated blood, and a high PO 2 . Warm temperature, normal pH, and high levels of 2, 3-DPG all favor release of O 2 at the tissues.
 Determinants of blood flow in normal coronary arteries.
CBF varies directly with the pressure difference across the coronary bed [coronary perfusion pressure (CPP)] and inversely with coronary vascular resistance (CVR):
However, coronary artery blood flow is autoregulated (i.e., resistance varying directly with perfusion pressure) so that flow is relatively independent of CPP between 50 and 150 mmHg but is pressure dependent outside of this range. Metabolic, autonomic nervous system, hormonal, and anatomic parameters alter CVR, and hydraulic factors influence CPP. Coronary stenoses also increase CVR.
1. Control of CVR. e) Endothelial modulation. Nitric oxide, which is released from the endothelium in response to chemical stimuli and mechanical vessel stress, is responsible for a cyclic guanosine monophosphate (c-GMP)-mediated vasodilatory effect on vascular smooth muscle. Nitric oxide also may contribute to vessel patency and blood flow by inhibiting platelet adhesion. PGI2 and endothelium-derived hyperpolarizing factor, which are released by the vascular endothelium, also cause relaxation of vascular smooth muscle. Endothelin, an extremely potent vasoconstrictor that is released by vascular endothelium, does not appear to be significantly involved in the regulation of myocardial blood flow under normal physiologic conditions.
f) Anatomic factors
-Capillary/myocyte ratio. There is an almost 1:1 ratio of capillaries to myocytes in the human myocardium. However, only three to four fifths of these capillaries function during normal conditions. During exercise, episodes of hypoxia, or extreme myocardial O 2 demand, the additional unopened capillaries are recruited and increase blood flow, causing a decrease in CVR. This decreases the intercapillary distance and thus the diffusion distance of O 2 to a given myocyte. This adaptation, along with coronary vasodilation, contributes to coronary vascular reserve.
-Coronary collaterals. Under most circumstances, they are nonfunctional. However, in the presence of impeded CBF, these coronary channels may enlarge over time and become functional. g) Other factors affecting CVR. CVR may be partly regulated by myogenic control of vessel diameter, which dynamically responds to the distending pressure inside the vessel. CVR varies linearly with blood viscosity. High hematocrit and hypothermia both increase viscosity dramatically, thus adversely increasing CVR. For these reasons, hemodilution is necessary when inducing hypothermia.
Hydraulic factors and subendocardial blood flow
a) LV subendocardial blood flow. Unlike CBF in the low-pressure right ventricular system, LV subendocardial blood flow is intermittent and occurs only during the diastolic portion of the cardiac cycle. Of the total LV coronary flow, 85% occurs during diastole and 15% occurs in systole (primarily in the epicardial region).
b) Coronary perfusion pressure. CPP equals the arterial driving pressure less the back-pressure to flow across the coronary bed.
CPP = Aortic diastolic blood pressure -LVEDP
Because diastole shortens relative to systole as heart rate increases, subendocardial blood flow is decreased at extremely rapid heart rates.
 Determinants of myocardial blood flow in stenotic coronaries.
In addition to the physiologic determinants of myocardial blood flow in normal coronary arteries, stenotic vessels add pathologic determinants of myocardial blood flow. Stenoses increase CVR and decrease CBF.
Types of coronary stenoses
a) Fixed or dynamic. A fixed stenosis is composed of an atherosclerotic plaque. A dynamic stenosis can occur in a region of a normal coronary artery, such as occurs in Prinzmetal variant angina or vasospastic angina. A combination of dynamic stenosis superimposed on an obstructive lesion may occur, particularly in patients with unstable angina pectoris.
b) Focal or segmental. The length of a coronary artery lesion can be short (focal) or long (segmental). Given the same decrease in cross-sectional area, a longer segmental stenosis of a coronary artery increases CVR more, thus reducing coronary flow more than would a short focal coronary stenosis (Poiseuille's law).
2. Degree of stenosis. CBF is reduced in proportion to the fourth power of the vessel diameter. Angiographically, a 50% diameter decrease in lumen size corresponds to a 75% reduction in cross-sectional area, which is hemodynamically consistent with symptoms of angina on exertion. A 75% reduction in diameter at angiography corresponds to a 94% reduction in cross-sectional area, which corresponds clinically to symptoms of angina at rest. Two discrete lesions in the same coronary artery will result in two tandem pressure drops, creating an impact on coronary flow in an additive fashion.
Collateral channels.
If the stenotic coronary lesion develops slowly, then collateral channels will enlarge to provide additional blood supply to a jeopardized region of the myocardium to prevent ischemia. However, as the degree of coronary stenosis increases, the collateral channels may not be adequate.
Patterns of stenoses.
A left main coronary stenosis limits blood flow to a large amount of the LV muscle mass. High-grade, very proximal stenotic lesions of both the circumflex and left anterior descending systems have the same physiologic implications as does a left main stenosis. Prognostically, however, a left main stenosis is more severe because only one vessel needs to become completely occluded to compromise a large amount of myocardial muscle.
5. Diffuse distal coronary disease. diffuse distal disease may be present in the small branches of the coronary vessels distal to where a graft could be placed. This diffuse disease further reduces blood flow to the myocardium and lessens the effectiveness of bypassing proximal coronary obstructions.
Associated disease states
a) Diabetic patients. Diabetic patients have been shown to have abnormal coronary microvasculature consisting of thickened capillary basement membranes that limit the diffusion of O 2 to the myocytes.
b) Hypertensive patients. Hypertensive patients are at increased risk for subendocardial ischemia. Hypertension is associated with LV hypertrophy. Because of increased wall thickness, the compressive forces on the coronary arteriole and O 2 demand in hypertensive patients are even greater in the subendocardium compared to those in normal individuals. A combination of LV hypertrophy with severe coronary stenosis places a patient at increased risk for development of subendocardial ischemia.
Myocardial oxygen demand
Direct measurement of myocardial oxygen demand is not feasible in the clinical setting. The product of heart rate and systolic pressure (rate-pressure product) sometimes is used as an easily obtainable clinical indicator of myocardial oxygen demand. The three major determinants of myocardial O 2 demand are heart rate, contractility, and wall stress.
1. Heart rate. O 2 demand per minute increases with heart rate increase.
Contractility.
More O 2 is used by a highly contractile heart compared with a more relaxed heart.
3. Wall stress. The stress in the ventricular wall depends on the pressure in the ventricle during contraction (afterload), the chamber size (preload), and the wall thickness. The calculation for a sphere (which we shall assume for the shape of the ventricle, for the sake of simplicity) is as follows:
Wall stress= pressure x radius / 2 (wall thickness) a) Chamber pressure. Oxygen demand increases with chamber pressure. Systemic blood pressure usually reflects the chamber pressure; thus, systemic blood pressure is equated with LV afterload.
b) Chamber size. Increased chamber size is associated with more modest increases in O 2 demand.
FIG. 2 Summary of factors that affect myocardial oxygen supply and demand

Monitoring for myocardial ischemia
Typical monitoring for CABG surgery includes the standard (ASA) monitors and invasive arterial blood pressure monitoring. Although TEE is used more frequently in current practice, it is not considered the standard of care for routine procedures. The use of PA catheters for routine CABG also is highly variable. Detection and treatment of intraoperative ischemia is critically important because intraoperative ischemia is an independent predictor of postoperative myocardial infarction.
ECG monitoring
Despite the increasing use of intraoperative TEE to detect new ischemic wall-motion abnormalities, continuous multilead ECG monitoring still is a standard monitor of intraoperative ischemia. A particular advantage of ECG monitoring for myocardial ischemia is that it may be accomplished before and during the induction of anesthesia, when it is impossible to use TEE. 
PA pressure monitoring
At many institutions, PA catheters are not considered necessary for the intraoperative management of routine coronary bypass surgery. However, at times, PA catheters are placed by the anesthesiologist for use in the postoperative setting, when it often is more difficult to utilize TEE. Additionally, the oximetric capabilities of special PA catheters can be used to determine mixed venous oxygen saturation.
The absolute PA pressure is not diagnostic of ischemia. Elevations of PA pressure or pulmonary capillary wedge pressure may occur secondary to valvular heart disease, rapid volume infusion, alterations in table positioning, use of vasoactive agents, or light anesthesia in the absence of ischemia. The morphology of the waveform, however, is more predictive.
Appearance of a new V wave on the pulmonary capillary wedge pressure waveform indicates functional mitral regurgitation, which is due to valvular pathology or papillary muscle dysfunction from ischemia. A new V wave suggestive of ischemia may occur before or in the absence of ECG changes. However, detection of changes on the pulmonary capillary wedge waveform requires frequent wedging of the PA catheter, a questionable practice in heparinized patients because of the possibility of PA rupture. Often the morphology of the PA pressure tracing will change when a new V wave appears on the wedge tracing. When the PA pressure wave changes shape, check the wedge for a new V wave.
FIG. 3
Hypertension from incision leading to an ischemic episode, demonstrated by the appearance of significant A, C, and V waves in the pulmonary capillary wedge pressure (PCWP) trace. These resolve with the institution of intravenous nitroglycerin. Note the lack of significant changes on the electrocardiogram (V 5) during this episode. BP, blood pressure. (Modified From Kaplan JA, Wells PH. Early diagnosis of myocardial ischemia using the pulmonary arterial catheter.
Transesophageal echocardiography
TEE has become an invaluable clinical tool and is used routinely at many institutions for most CABG surgery.
 General indications for TEE during revascularization procedures. TEE is used to assess ventricular preload and contractility, detect myocardial ischemia, evaluate the aortic cannulation site, detect concomitant valve pathology, detect the presence and pathophysiologic effect of pericardial effusion, aid the placement of intraaortic balloon catheters and coronary sinus catheters, and detect the presence of ventricular aneurysms and ventricular septal defects. 
Anesthetic effects on myocardial oxygen supply and demand
A. Intravenous nonopioid agents 1. Thiopental induction doses decrease systemic vascular resistance (SVR) and cardiac contractility and increase heart rate. So, the net effect on myocardial O 2 balance is not easily predicted.
2. Ketamine administration is accompanied with an increase in sympathetic tone leading to increases in SVR, filling pressures, contractility, and heart rate. Myocardial O 2 demand is strongly increased, whereas O 2 supply may be only slightly augmented, thus producing ischemia. Ketamine is not recommended for routine use in patients with ischemic heart disease. It is, however, sometimes used in the setting of tamponade physiology because of its ability to preserve heart rate, contractility, and SVR.
3. Etomidate. Induction doses (0.2 to 0.3 mg/kg) do not alter heart rate or cardiac output, although mild peripheral vasodilation may lower blood pressure slightly. As such, it is an ideal drug for rapid induction of anesthesia in patients with ischemic heart disease. Etomidate offers little protection from the increases in heart rate and blood pressure that accompany intubation. It usually is necessary to supplement etomidate with other agents (e.g., opioids, benzodiazepines, volatile agents, -blockers, and nitroglycerin) in order to control the hemodynamic profile and prevent myocardial O 2 supply/demand inequality. An induction dose will block adrenal steroidogenesis for 6 to 8 hours.
4. Benzodiazepines. Midazolam (0.2 mg/kg) or diazepam (0.5 mg/kg) may be used to induce anesthesia. Although both agents are compatible with the goal of maintaining hemodynamic stability, blood pressure may decrease more with midazolam owing to more potent peripheral vasodilation. Negative inotropic effects are inconsequential. Blood pressure and filling pressures decrease with induction, whereas heart rate remains essentially unchanged.
Propofol.
The cardiovascular effects of induction doses of propofol are similar to those of the thiobarbiturates: systemic blood pressure, SVR, and cardiac contractility decrease. Heart rate may increase less with propofol compared to thiopental.
6. 2-Adrenergic agonists result in a reduction in stress-mediated neurohumoral response and therefore are associated with decreases in heart rate and blood pressure. These agents typically are used during maintenance of anesthesia or postoperatively. There is some evidence suggesting that use of oral clonidine may be associated with a reduced incidence of perioperative myocardial ischemia in patients undergoing CABG surgery. Dexmedetomidine is associated with a greater relative 2 selectivity than clonidine. Both agents have sedative and antinociceptive characteristics. Use of 2-adrenergic agonists is associated with a reduced opioid requirement. Additionally, 2-adrenergic agonists do not result in respiratory depression.
B. Volatile agents.
In general, they decrease both O 2 supply and demand. The net effect on the myocardial supply/demand equality depends upon the hemodynamic profile that prevails at the time of administrations.
1. Heart rate. If heart rate is high, halothane decreases it; if heart rate is low, halothane has little effect. Sevoflurane is associated with a negligible effect on heart rate. Enflurane, desflurane, and isoflurane often cause an increase in heart rate. Isoflurane also may decrease heart rate if the decrease in SVR is not profound, if the carotid baroreceptor function is impaired, or if the patient is fullyblocked. Junctional rhythms, most often associated with enflurane, may occur with any volatile agent. Junctional rhythms deprive the heart of an atrial kick and lead to decreased stroke volume, cardiac output, and CBF, which may offset the salubrious effects of low heart rate.
Contractility.
All volatile anesthetics decrease contractility, which lowers O 2 demand. However, isoflurane and probably desflurane and sevoflurane are less depressant than halothane or enflurane. In decompensated hearts, however, all volatile anesthetics may decrease ventricular function.
3. Afterload. Decreases in cardiac output and SVR result in decreased systemic blood pressure with volatile anesthesia. Venodilation and blunted contractility account for the decrease in cardiac output. SVR decreases with isoflurane and desflurane, and perhaps with enflurane and sevoflurane, but is essentially unchanged during halothane administration. The decrease in diastolic blood pressure reduces myocardial O 2 supply, whereas the decreased afterload reduces O 2 demand. In the steady state, the cardiovascular actions of desflurane are similar to those of isoflurane. However, during induction without opioids, heart rate and systemic and PA blood pressures may increase and require therapeutic intervention.
Preload.
Volatile agent anesthesia is characterized by maintenance of filling pressures.
Coronary steal i.e. dilation of normal vascular beds diverts blood away from
other beds that are ischemic and thus maximally dilated .Coronary steal has been observed in canine models with isoflurane administration . It is doubtful that isoflurane-induced coronary steal is of significant clinical importance to patients undergoing coronary revascularization surgery so long as hypotension and consequent pressure-dependent coronary artery perfusion are avoided. Coronary steal has not been observed with halothane, enflurane, or desflurane.
Preconditioning.
Volatile anesthetics may confer a degree of preconditioning-like protective effect against ischemia-reperfusion injury in human myocardial tissue C. Nitrous oxide. The mild negative inotropic effects of nitrous oxide yield a decrease in contractility, producing a reduction in both O 2 supply and demand. Adding nitrous oxide to an opioid-oxygen anesthetic will decrease SVR due, in part, to the removal of the vasoconstrictive effects of 100% O 2 . The sympathomimetic effects of nitrous oxide counterbalance any direct depression of contractility except in patients with poor LV function in whom the myocardium already is highly stimulated intrinsically. Nitrous oxide does not appear to cause myocardial ischemia in patients with coronary artery disease.
D. Opioids
1. Heart rate. All opioids except meperidine decrease heart rate by a centrally mediated vagotonic effect (meperidine has an atropine-like effect).
Contractility.
Aside from meperidine, which decreases contractility, the opioids have little effect on contractility in clinical doses.
Afterload.
In compromised patients, the loss of sympathetic tone associated with opioid induction of anesthesia may result in a sudden drop in blood pressure and consequent decreases in both O 2 supply and demand.
Preload.
Despite a lack of histamine-releasing properties, fentanyl and sufentanil will reduce preload when administered in either moderate doses (25 µg/kg for fentanyl) or larger doses by decreasing intrinsic sympathetic tone. Oxygen demand is decreased.
Hyperdynamic state.
Elevations of heart rate, blood pressure, and cardiac output with or without decreased filling pressures are common during pure opioidoxygen anesthetic techniques in patients with good ventricular function. This highsupply/high-demand state may be less preferable than the low-demand state achieved with volatile anesthesia. Additional opioid, which often fails to treat the hypertension associated with a hyperdynamic cardiac state, frequently decreases systemic blood pressure excessively when hypertension originates from increased SVR alone.
E. Muscle relaxants
1. Succinylcholine may cause a variety of dysrhythmias (bradycardia, tachycardia, extrasystoles), which may negatively affect myocardial O 2 balance.
2. Tubocurarine, metocurine iodide, and atracurium besylate. These drugs release histamine at one, two, and three times the dose for 95% twitch depression ED95, respectively. None is the drug of choice for patients with ischemic heart disease.
3. Pancuronium. Heart rate increases 20% when pancuronium is combined with a volatile anesthetic. With high-dose opioid anesthesia, heart rate usually remains stable. Occasionally a patient will develop tachycardia and ischemia during induction or intubation. Pancuronium also is known to increase systemic blood pressure, although the effects on O 2 balance in the heart are not predictable.
Vecuronium.
Vecuronium has a flat cardiovascular profile that is ideal with a lowor moderate-dose opioid anesthetic supplemented by volatile agent. Bradycardia may occur when it is given in conjunction with rapid injection of high doses of the highly lipid-soluble opioids.
5. Doxacurium. Although devoid of cardiovascular perturbation when injected slowly by a peripheral vein, this long-acting agent may release sufficient histamine when given rapidly by a central vein to induce a reflex tachycardia.
6. Mivacurium. Histamine release at doses greater than twice the ED95 and a short duration of action render this drug inappropriate for routine myocardial revascularization procedures.
Rocuronium.
Although the drug is a more potent vagal blocker than vecuronium, it is less potent than pancuronium. Consequently, tachycardia is possible but less likely than with pancuronium. Rocuronium administration does not result in significant perturbations in other hemodynamic parameters.
Cisatracurium. Has insignificant hemodynamic effects.
To summarize. Volatile anesthesia provides a low-supply/low-demand environment. The opioid-oxygen technique provides a high-supply/high-demand environment. Success with either technique depends on maintaining proper balance, with O 2 supply exceeding demand.
Anesthetic approach for myocardial revascularization procedures A. Fast-track cardiac anesthesia
Until the 1990s, anesthesia for cardiac surgery was based on a high-dose narcotic technique that was considered to be compatible with minimal impairment of cardiac function and, therefore, was conducive to the maintenance of perioperative hemodynamic stability.
In the last decade, the emergence of new surgical techniques, improved myocardial protection, warmer bypass temperatures (32° to 34°C), improvements in anesthetic technique, management of perioperative coagulopathy, and temperature homeostasis (e.g., warmer operating room temperatures and use of active warming devices) have allowed the further development of fast-track cardiac anesthesia.
In the present economic climate, high-dose narcotic technique is less frequently considered to be necessary or appropriate. However, high-dose narcotic technique may be used when early extubation is not considered a realistic goal. Additionally, high-dose narcotic technique may be used when it is absolutely necessary to avoid precipitous changes in hemodynamic conditions, such as when there are surgical concerns about anastomotic or aortic cannulation site integrity.
Fast-track cardiac anesthesia is a method of anesthetic management that promotes rapid recovery. It may be associated with reduced health care costs and improved clinical outcome.
Early fast-track initiative exclusion criteria included obesity, moderate-to-severe pulmonary disease, emergency operations, poor ventricular function, combined procedures, redo operations, and advanced age. Presently, an attempt to deliver anesthesia that is compatible with enhanced recovery is made in most patients unless they are hemodynamically compromised or difficult airways. Poor LV function is not necessarily considered to be an absolute contraindication to fast tracking so long as hemodynamic stability is maintained. It is imperative to continuously evaluate the patient for the appropriateness of enhanced recovery as the operation progresses.
Anesthetic management
 Premedication. Long-acting agents such as scopolamine are preferentially avoided. In this scenario, it may be useful to allay anxiety with a rapid-acting agent such as midazolam (0.03 to 0.07 mg/kg IV).
 Intraoperative anesthetic agent management  Induction of anesthesia. In order to limit the total opioid dose, it is necessary to supplement opioid with IV and/or volatile anesthetic agents. Typically etomidate, propofol, or thiopental is used to accomplish the induction of anesthesia. If etomidate is used (0.3 mg/kg), it often is necessary to use an additional agent, such as a low-dose narcotic, to avoid tachycardia and hypertension. Additionally, judicious use of short-acting -blocking agents (e.g., esmolol) and/or nitroglycerin may be required to maintain hemodynamic stability during induction with a lowdose narcotic technique.
 Maintenance of anesthesia. Anesthesia is maintained with a variable combination of volatile agents, low-dose narcotics, and IV hypnotic agents. The ultra-short-acting opioid remifentanil is associated with good hemodynamic stability, adequate attenuation of the neurohumoral stress response, and early awakening. However, due to its short half-life, it requires supplemental analgesia in the postoperative period. When volatile agents are used, it is important to reduce the reliance upon the volatile agent in advance of patient transport to the ICU. Otherwise, the patient may become acutely hyperdynamic upon arrival to the ICU, prompting the use of long-duration sedatives by the ICU staff.
-2-Agonists (e.g., dexmedetomidine and clonidine) are used adjunctively because of their ability to reduce the neurohumoral stress response in addition to their sedative and antinociceptive properties. These agents may reduce the anesthetic requirement and therefore may facilitate a more rapid emergence from anesthesia. Dexmedetomidine is approved for use as a postoperative sedative and is administered as an infusion (0.2 to 0.7 µg/kg/hour).
-Intrathecal and epidural analgesia may facilitate recovery by decreasing the perioperative opioid requirements. Concern about neuroaxial hematoma formation in the presence of systemic anticoagulation limits the clinical application of regional anesthesia.
 Intraoperative awareness. it is imperative to match the level of anesthesia to the operative stress at different times during the procedure to avoid harmful hemodynamic response to stimulation and the possibility of intraoperative recall. Frequently, volatile agents are administered while the patient is on bypass with a vaporizer attached to the cardiopulmonary bypass circuit. The bispectral index (BIS) monitor has been used during cardiac surgery in an effort to avoid intraoperative awareness.
 Temperature homeostasis. Attention to heat preservation is critically important when early extubation is anticipated because hypothermia will delay respiratory weaning and may be associated with postoperative arrhythmias and coagulopathy. Additionally, hypothermia may precipitate shivering, which significantly raises myocardial oxygen consumption. IV fluid warmers may be of great clinical utility, especially when there are large transfusion requirements. Forced hot-air convective warming is the best means of preserving body temperature during off-bypass revascularization.
 Hemostatic homeostasis. Scrupulous surgical attention to hemostasis may be supplemented by the use of pharmacologic hemostatic agents such as aminocaproic acid and tranexamic acid. Use of these agents generally is restricted to revascularization that involves the use of bypass. Both agents are associated with reduced bleeding and subsequent need for transfusion of blood products in the postoperative period.
 Intraoperative extubation. In the absence of ventricular impairment, hemodynamic instability, hypothermia, or significant coagulopathy, intraoperative tracheal extubation may be considered. However, extubation in the operating room may not confer any significant clinical or economic benefit to the patient.
ICU management
The goal is to maintain a degree of sedation with a relatively short-acting agent that is devoid of significant hemodynamic effect (e.g. Propofol), until such time as the patient is deemed ready for weaning from mechanical ventilation. For an uncomplicated patient, it is reasonable to tailor the level of sedation to accomplish extubation 4 to 8 hours postoperatively. This amount of time allows the patient to recover from inadequate myocardial protection during cardiopulmonary bypass, to achieve temperature homeostasis, and to be treated for perioperative coagulopathy .It may be advisable to have nitroglycerin immediately available as an IV drip for rapid titration to desired blood pressure.
Clinical and economic benefits
Clinical benefits. Early extubation may be associated with reduced postoperative lung atelectasis and improved pulmonary shunt fraction. Positive-pressure ventilation has deleterious effects on cardiac output and organ perfusion that may be minimized by early extubation. Early chest tube removal facilitates patient mobilization. Early extubation yields greater patient satisfaction as long as appropriate analgesia is maintained.
Economic benefits. Early extubation protocol reduces ICU stay and hospital stay, and it may reduce the total cost of surgery by as much as 25%.
B. Special circumstances
 Off-pump coronary artery bypass (OPCAB) and minimally invasive direct coronary artery bypass (MIDCAB)
 Advantages -MIDCAB and OPCAB reduce the whole-body "inflammatory response" induced by surgery and extracorporeal circulation. This might be expected to reduce fluid requirements and coagulopathy -Avoidance of aortic manipulation and cannulation might reduce embolic complications such as stroke.
-Most published reports indicate a reduced need for transfusion. This probably is multifactorial, owing to the lack of hemodilution (avoidance of pump prime), and hypothermia, as well as the lack of blood exposure to extracorporeal surfaces and to high doses of heparin and protamine.
-Avoidance of sternotomy in MIDCAB.
 Requirements -Surgical adjuncts to reduce ischemia e.g. intracoronary shunts, ischemic preconditioning, perfusion-assisted direct coronary artery bypass, preoperative insertion of an intraaortic balloon pump.
-If incisions other than sternotomy (MIDCAB) are to be used to access specific coronary regions, positioning of the arms and the body, the potential need for one-lung anesthesia, and the sites for vascular access need to be discussed.
-Avoid hypothermia.
-Good monitoring:
Lead V5 of the electrocardiogram (ECG) detects 75% of the ischemia found on all 12 leads.
TEE, is used for .Volumetric assessment of preload especially in patients with an elevated LVEDP who may have a "stiff" ventricle, or diastolic dysfunction.
.Assessment of tolerance to coronary occlusions and the need for inotropic and/or vasopressor infusions.
The PAC is variably useful during OPCAB. For single-or double-vessel bypass in patients with preserved left ventricular function, there is little need for this monitor.
The worse the ventricular function and the greater the number of planned bypass grafts, the more likely it is that information from the PAC will be useful.
Preoperative placement of a large-bore central venous introducer, but with an obturator of some kind rather than a PAC, may be a reasonable first approach in most patients. This avoids use of the PAC in uncomplicated patients while allowing for rapid PAC placement should this is necessary at any time in the perioperative period.
*Continuous cardiac output from the PAC or other devices.
-Early recovery usually is desired. Extubation immediately or shortly after surgery should be the goal.
-Anticipation and management of ischemia: pharmacologic preconditioning, avoidance of hemodynamic alterations associated with ischemia such as tachycardia (intravenous β-adrenergic blockade may be beneficial), maintenance of adequate coronary perfusion pressure (intravascular volume loading, trendelenburg position, reduction in the depth of anesthesia, and/or use of α-adrenergic agonists).
-Intravascular volume loading: Positioning of the heart may kink or partially obstruct venous return and/or compress the right ventricle. Intravascular volume loading and head-down (Trendelenburg) position can help reduce this effect -Surgery-anesthesiology interaction.
 Urgent CABG
Patients present for urgent coronary artery bypass surgery for treatment of angina refractory to maximal nonsurgical management or in the setting of a clinical misadventure in the catheterization/angioplasty suite. Often these patients are hemodynamically unstable and should be transported by physicians who are knowledgeable about the patient's present medical condition, with full monitoring, oxygen, and emergency medications. Upon arrival in the operating room, it is essential to establish monitoring and proper IV access in an expeditious and safe fashion. It is customary to begin the operation without the delay that would be engendered by establishing alternate central venous access.
Induction of anesthesia usually is accomplished with short-acting agents (e.g., etomidate) that do not compromise hemodynamic conditions. Short-acting agents are preferable in the event that induction of anesthesia and consequent attenuation of sympathetic tone result in hemodynamic collapse. Every effort should be made to place the patient on cardiopulmonary bypass without delay. In the event that the patient is unable to tolerate adequate anesthesia, an effort should be made to provide protection from intraoperative awareness with an amnestic agent (e.g., scopolamine). Depending upon the extent of preoperative myocardial damage and the success of revascularization, inotropic support and/or mechanical assistance may be necessary to successfully separate the patient from bypass.
 Poor LV function. Patients with poor ventricular function (ejection fraction less than 35%) should receive a reduced dose of premedication under monitored conditions. With severe ventricular compromise, it may be necessary to initiate therapy with inotropic agents before the induction of anesthesia. Induction of anesthesia is accomplished with short-acting agents that are devoid of significant hemodynamic effect (e.g., etomidate). It usually is possible to slowly titrate IV opioids to achieve adequate anesthetic depth. If ventricular function is not expected to improve significantly as a result of revascularization, appropriate inotropic agents should be used to separate the patient from cardiopulmonary bypass.
 Patients with critical coronary artery disease. In patients with severe coronary artery disease (left main or left main equivalent disease), even brief episodes of myocardial oxygen supply/demand imbalance may not be tolerated. It is necessary to assiduously avoid increases in heart rate, contractility, or wall tension. It also is imperative to maintain CPP. If nitroglycerin is being used, it should be continued until the cross-clamp is applied (i.e., abolishment of coronary flow). These patients generally fare better with a high-supply/high-demand anesthetic technique rather than a low-supply/low-demand technique.
 CABG for patients previously treated with antiplatelet medications.
Patients treated with antiplatelet agents are at risk for significant coagulopathy and consequent bleeding. It often is necessary to treat these patients empirically with platelet infusions to avoid catastrophic blood loss and high transfusion requirements.
 CABG for patients with heparin-induced thrombocytopenia. Management of cardiopulmonary bypass for patients with heparin-induced thrombocytopenia is :
-Change tissue source, plasmapheresis, LMWH, heparinoids, heparin plus platelet inhibitors, hirudin, argatroban, and ancrod.
-If heparin can be discontinued for a few weeks to months, often the antibody will disappear and allow a brief period of heparinization for CPB without complication.
 Redo CABG procedures. An increased incidence of bleeding, perioperative ischemia, infarction, and pump failure are the main concerns that lead to increased morbidity and mortality in this subgroup of patients undergoing myocardial revascularization.
 Patients with acute ischemic mitral regurgitation on the basis of ischemic papillary muscle dysfunction or ruptured chordae tendineae often are hemodynamically unstable and may present for surgical repair and revascularization without the benefit of maximal preoperative preparation. In brief, acute mitral insufficiency is associated with tachycardia, high LVEDP, and increased contractility, which all may serve to worsen the already compromised myocardial oxygen supply/ demand dynamic. Because the intraaortic balloon pump frequently stabilizes these patients sufficiently to permit survival until operation, its continued use until establishment of bypass is essential.
Causes of perioperative myocardial ischemia
A. Causes of ischemia in the prebypass period LVEDP is increased.) On the other hand indiscriminate use of inotropes may aggravate ischemia. Therefore, preload, heart rate rhythm, and afterload all should be maximized before inotropes are used.
Correction of surgical complications and mechanical problems
a. Any surgical correctable factors leading to ischemia should be attended to in the postbypass period.
b. Overinflation of the lungs when an IMA graft is present should be avoided.
c. If residual air in the coronary arteries is suspected, pharmacologic elevation of systemic blood pressure or manual myocardial contraction may help dislodge air from the coronary circulation.
3. Treatment of coronary spasm. IV or sublingual nifedipine and IV nitroglycerin, diltiazem, and nicardipine are therapeutic options for treating coronary spasm.
Specific pharmacologic treatment of ischemia. This treatment includes
nitroglycerin, B-blockers, and calcium channel blockers. Because ischemia frequently occurs from thrombus formation on atheroma, many nonsurgical patients receive heparin as acute therapy and antiplatelet agents (most commonly aspirin) for longterm prophylaxis. These agents should be withheld after bypass until the threat of surgical hemorrhage ceases.
Mechanical support.
a. Intraaortic balloon pumps.
b. Right and LV assist devices.
6. Ischemic preconditioning. Tissue injury resulting from ischemia and subsequent tissue reperfusion may involve a reduction in adenosine triphosphate (ATP) levels, free oxygen radicals, and calcium-mediated injury. A brief period of tissue ischemia "ischemic preconditioning" may protect against the damage caused by subsequent prolonged ischemia and tissue reperfusion. Endogenously produced adenosine may mediate ischemic preconditioning via enhanced preservation of ATP, inhibition of platelet and neutrophil-mediated inflammatory tissue injury, vasodilation, and decreased basal cellular energy requirements related to intracellular hyperpolarization. Adenosine and some volatile anesthetics may confer a degree of a preconditioning-like protective effect.
7.
Postconditioning. Recent studies indicate that multiple, brief coronary occlusions during the initial minutes of reperfusion following prolonged ischemia can reduce myocardial infarct size to a similar extent as ischemic preconditioning. This adaptive response is referred to as ischemic postconditioning.
